Geron Announces September Investor Conference Presentation Webcasts

Rhea-AI Summary

Geron Corporation (NASDAQ: GERN) announced that Dr. John A. Scarlett, its Chairman and CEO, will present at three upcoming investor conferences in September 2021. The presentations include the H.C. Wainwright 23rd Annual Global Virtual Investment Conference on September 13, R.W. Baird 2021 Virtual Global Healthcare Conference on September 14, and Cantor Virtual Global Healthcare Conference on September 30. Live webcasts of the presentations will be available through Geron's Investor Relations webpage, with archived replays for 30 days.

Positive

• Upcoming presentations could enhance investor interest in GERN.
• Live webcasts of presentations increase transparency and accessibility.

Negative

• None.

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following investor conferences:

• H.C. Wainwright 23rd Annual Global Virtual Investment Conference on Monday, September 13, 2021 at 7:00 a.m. ET.
• R.W. Baird 2021 Virtual Global Healthcare Conference on Tuesday, September 14, 2021 at 2:00 p.m. ET.
• 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30, 2021 at 3:20 p.m. ET.

A live webcast of each presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentations, the webcasts will be archived and available for replay for a period of 30 days.

About Geron

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis. For more information about Geron, visit www.geron.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005369/en/

Olivia Bloom

Chief Financial Officer

investor@geron.com

media@geron.com

Source: Geron Corporation

FAQ

What is the schedule for Geron's presentations in September 2021?

Geron will present at three conferences: H.C. Wainwright on September 13 at 7:00 a.m. ET, R.W. Baird on September 14 at 2:00 p.m. ET, and Cantor on September 30 at 3:20 p.m. ET.

Where can I watch Geron's investor presentations?

Webcasts of the presentations will be available on Geron's Investor Relations section of their website.

What is Geron Corporation working on currently?

Geron is focused on developing its telomerase inhibitor, imetelstat, for hematologic myeloid malignancies, conducting two Phase 3 trials.